1. Home
  2. ADVM vs ASYS Comparison

ADVM vs ASYS Comparison

Compare ADVM & ASYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • ASYS
  • Stock Information
  • Founded
  • ADVM 2006
  • ASYS 1981
  • Country
  • ADVM United States
  • ASYS United States
  • Employees
  • ADVM N/A
  • ASYS N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • ASYS Industrial Machinery/Components
  • Sector
  • ADVM Health Care
  • ASYS Technology
  • Exchange
  • ADVM Nasdaq
  • ASYS Nasdaq
  • Market Cap
  • ADVM 94.6M
  • ASYS 83.0M
  • IPO Year
  • ADVM 2014
  • ASYS N/A
  • Fundamental
  • Price
  • ADVM $4.32
  • ASYS $7.20
  • Analyst Decision
  • ADVM Buy
  • ASYS
  • Analyst Count
  • ADVM 5
  • ASYS 0
  • Target Price
  • ADVM $16.60
  • ASYS N/A
  • AVG Volume (30 Days)
  • ADVM 1.0M
  • ASYS 249.3K
  • Earning Date
  • ADVM 11-07-2025
  • ASYS 12-08-2025
  • Dividend Yield
  • ADVM N/A
  • ASYS N/A
  • EPS Growth
  • ADVM N/A
  • ASYS N/A
  • EPS
  • ADVM N/A
  • ASYS N/A
  • Revenue
  • ADVM $1,000,000.00
  • ASYS $83,634,000.00
  • Revenue This Year
  • ADVM $1,449.40
  • ASYS N/A
  • Revenue Next Year
  • ADVM N/A
  • ASYS $12.93
  • P/E Ratio
  • ADVM N/A
  • ASYS N/A
  • Revenue Growth
  • ADVM N/A
  • ASYS N/A
  • 52 Week Low
  • ADVM $1.78
  • ASYS $3.20
  • 52 Week High
  • ADVM $8.18
  • ASYS $10.80
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 50.91
  • ASYS 39.43
  • Support Level
  • ADVM $4.18
  • ASYS $7.80
  • Resistance Level
  • ADVM $4.34
  • ASYS $8.46
  • Average True Range (ATR)
  • ADVM 0.26
  • ASYS 0.45
  • MACD
  • ADVM -0.05
  • ASYS -0.09
  • Stochastic Oscillator
  • ADVM 40.96
  • ASYS 3.38

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About ASYS Amtech Systems Inc.

Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.

Share on Social Networks: